Allosteric effect on muscarinic M2-receptors of derivatives of the alkane-bis-ammonium compound W84: comparison with bispyridinium-type allosteric modulators
暂无分享,去创建一个
[1] E. El-Fakahany,et al. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.
[2] O. Wassermann,et al. Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds. , 1969, European journal of pharmacology.
[3] E. El-Fakahany,et al. Allosteric antagonists of the muscarinic acetylcholine receptor. , 1991, Biochemical pharmacology.
[4] E. El-Fakahany,et al. Allosteric interaction of dynorphin and myelin basic protein with muscarinic receptors. , 1993, Pharmacology.
[5] V. Bertolasi,et al. Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands. , 1987, Molecular pharmacology.
[6] J. Proska,et al. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. , 1994, Molecular pharmacology.
[7] U. Holzgrabe,et al. Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors. , 1994, Journal of medicinal chemistry.
[8] K. Mohr,et al. Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication. , 1988, Pharmacology & toxicology.
[9] D. Mash,et al. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. , 1992, Molecular pharmacology.
[10] O. Wassermann,et al. Action of atropine and some hexane-1.6-bis-ammonium derivatives upon the toxicity of DFP im mice. , 1968, European Journal of Pharmacology.
[11] G. Biggio,et al. Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors. , 1990, European journal of pharmacology.
[12] C. Forray,et al. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands. , 1992, Molecular pharmacology.